(Q40031348)

16 September 2017

title

A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes (English)

1 reference

16 September 2017

1 reference

1 reference

Hu ZB

1

1 reference

16 September 2017

Wu CT

2

1 reference

16 September 2017

Wang H

3

1 reference

16 September 2017

Zhang QW

4

1 reference

16 September 2017

Wang L

5

1 reference

16 September 2017

Wang RL

6

1 reference

16 September 2017

Lu ZZ

7

1 reference

16 September 2017

Wang LS

8

1 reference

16 September 2017

publication date

21 December 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

15

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

173-182

1 reference

Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

Current developments in adenovirus-based cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Gene therapy clinical trials worldwide 1989-2004-an overview.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Development of transcriptionally regulated oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Modified adenoviruses for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Sensitivity and reproducibility in adenoviral infectious titer determination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Gene therapy for cancer treatment: past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Telomerase activity in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Telomerase-dependent oncolytic adenovirus for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Effects of the Ad5 upstream E1 region and gene products on heterologous promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Telomerase maintains telomere structure in normal human cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Exploiting internal ribosome entry sites in gene therapy vector design.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701105

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701105

1 reference

Dimensions Publication ID

16 September 2017

1009749636

0 references

1 reference